Author:
Gang A.O.,Strøm C.,Pedersen M.,d’Amore F.,Pedersen L.M.,Bukh A.,Pedersen B.B.,Moeller M.B.,Mortensen L.S.,Gadeberg O.V.,Ingeberg S.,Mourits-Andersen T.,Pulczynski S.,Brown P.d. Nully
Reference26 articles.
1. The Recommendation from the Danish Lymphoma Group for Diagnostic and Treatment of Diffuse Large B-Cell LymphomaAnnual report 2008; www.lymphoma.dk (7 March 2011, date last accessed)
2. CHOP is curative in thirty percent of patients with large cell lymphoma: a twelve year Southwest Oncology Group follow-up;Coltman,1986
3. Hydroxydaunomycin (adriamycin) combination chemotherapy in malignant lymphoma;McKelvey;Cancer,1976
4. Phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin’s lymphoma;Vose;J Clin Oncol,2001
5. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002
Cited by
63 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献